The Bakersfield Californian

Vaccinatio­n drive enters new phase in US and Britain

- BY EUGENE GARCIA AND DANICA KIRKA

The first Americans inoculated against COVID-19 began rolling up their sleeves for their second and final dose Monday, while Britain introduced another vaccine on the same day it imposed a new nationwide lockdown against the rapidly surging virus.

New York State, meanwhile, announced its first known case of the new and seemingly more contagious variant, detected in a man in his 60s in Saratoga

Springs.

Colorado,

California and Florida previously reported infections involving the mutant version that has been circulatin­g in England.

The emergence of the variant has added even more urgency to the worldwide race to vaccinate people against the scourge.

In Southern California, intensive care nurse Helen Cordova got her second dose of the Pfizer vaccine at Kaiser Permanente Los Angeles Medical Center along with other doctors and nurses, who bared their arms the prescribed three weeks after they received their first shot. The second round of shots began in various locations around the country as the U.S. death toll surpassed 352,000.

“I’m really excited because that means I’m just that much closer to having the immunity and being a little safer when I come to work and, you know, just being around my family,” Cordova said.

Over the weekend, U.S. government officials reported that vaccinatio­ns had accelerate­d significan­tly. As of Monday, the Centers for Disease Control and Prevention said nearly 4.6 million shots had been dispensed in the U.S., after a slow and uneven start to the campaign, marked by confusion, logistical hurdles and a patchwork of approaches by state and local authoritie­s.

Britain, meanwhile, became the first nation to start using the COVID-19 vaccine developed by AstraZenec­a and Oxford University, ramping up its nationwide inoculatio­n campaign amid soaring infection rates blamed on the new variant. Britain’s vaccinatio­n program began Dec. 8 with the shot developed by Pfizer and its German partner BioNTech.

Brian Pinker, an 82-year-old dialysis patient, received the first Oxford-AstraZenec­a shot at Oxford University Hospital, saying in a statement: “I can now really look forward to celebratin­g my 48th wedding anniversar­y.”

The rollout came the same day Prime Minister Boris Johnson announced a new lockdown for England until at least mid-February. Britain has recorded more than 50,000 new coronaviru­s infections a day over the past six days, and deaths have climbed past 75,000, one of the worst tolls in Europe.

Schools and colleges will generally be closed for faceto-face instructio­n. Nonessenti­al stores and services like hairdresse­rs will be shut down, and restaurant­s can offer only takeout.

 ?? STEVE PARSONS / POOL PHOTO VIA AP ?? Brian Pinker, 82, receives the Oxford University/AstraZenec­a COVID-19 vaccine Monday from nurse Sam Foster at the Churchill Hospital in Oxford, England. Pinker, a retired maintenanc­e manager, received the first injection of the new vaccine developed between Oxford University and drug giant AstraZenec­a.
STEVE PARSONS / POOL PHOTO VIA AP Brian Pinker, 82, receives the Oxford University/AstraZenec­a COVID-19 vaccine Monday from nurse Sam Foster at the Churchill Hospital in Oxford, England. Pinker, a retired maintenanc­e manager, received the first injection of the new vaccine developed between Oxford University and drug giant AstraZenec­a.
 ?? WILFREDO LEE / AP ?? Syringes containing the Pfizer-BioNTech COVID-19 vaccine are shown before being administer­ed Monday at Jackson Memorial Hospital in Miami.
WILFREDO LEE / AP Syringes containing the Pfizer-BioNTech COVID-19 vaccine are shown before being administer­ed Monday at Jackson Memorial Hospital in Miami.

Newspapers in English

Newspapers from United States